Skip to main content
Top
Published in: Tumor Biology 2/2016

01-02-2016 | Original Article

∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299

Authors: Elisa Caiola, Eleonora Marrazzo, Simona Alesci, Massimo Broggini, Mirko Marabese

Published in: Tumor Biology | Issue 2/2016

Login to get access

Abstract

Caveolins have recently attracted attention for their possible involvement in signal transduction. Their role in cancer is debated, being reported both a suppressive and oncogenic role in different experimental conditions. Caveolin-1 is regulated by the tumor suppressor p53 which is able to bind its promoter and activate transcription. We had previous evidences indicating that a specific p73 isoform, namely ∆Np73β, when overexpressed in NCI-H1299 induced growth arrest and cell death. By gene expression analysis in cell transiently overexpressed with ∆Np73β, a strong induction of caveolin-1 was found. Caveolin was induced both at mRNA and protein level, and we characterised the promoter sequence of the gene encoding for caveolin-1 and found that the promoter region containing the putative p53 (and hence p73) binding sequence was responsive to ∆Np73β, but not to ∆Np73α and ∆Np73γ which do not induce growth arrest as ∆Np73β does. A reduction in cell adhesion was observed in ∆Np73β overexpressing cells, again supporting a possible role of caveolins in determining these effects. By using specific siRNA directed against human caveolin-1, we could not however antagonize the effects induced by ∆Np73β. Although caveolin-1 represents one of the genes whose expression is strongly activated by ∆Np73β, we could not define a role of caveolin-1 as a mediator of ∆Np73β associated growth arrest. It could well be that the expression of caveolin-1 is able to mediate other activities of ∆Np73β, and studies are in progress to determine whether its expression is mainly associated to metastatic spread.
Appendix
Available only for authorised users
Literature
2.
go back to reference Hehlgans S, Cordes N. Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance. Am J Cancer Res. 2011;1:521–30.PubMedPubMedCentral Hehlgans S, Cordes N. Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance. Am J Cancer Res. 2011;1:521–30.PubMedPubMedCentral
3.
4.
go back to reference Lin MI, Yu J, Murata T, Sessa WC. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 2007;67:2849–56.CrossRefPubMed Lin MI, Yu J, Murata T, Sessa WC. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 2007;67:2849–56.CrossRefPubMed
5.
go back to reference Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 map kinase cascade. EMBO J. 1998;17:6633–48.CrossRefPubMedPubMedCentral Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 map kinase cascade. EMBO J. 1998;17:6633–48.CrossRefPubMedPubMedCentral
6.
go back to reference Cantiani L, Manara MC, Zucchini C, De Sanctis P, Zuntini M, Valvassori L, et al. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-src activity and met signaling. Cancer Res. 2007;67:7675–85.CrossRefPubMed Cantiani L, Manara MC, Zucchini C, De Sanctis P, Zuntini M, Valvassori L, et al. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-src activity and met signaling. Cancer Res. 2007;67:7675–85.CrossRefPubMed
7.
go back to reference Ho CC, Huang PH, Huang HY, Chen YH, Yang PC, Hsu SM. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol. 2002;161:1647–56.CrossRefPubMedPubMedCentral Ho CC, Huang PH, Huang HY, Chen YH, Yang PC, Hsu SM. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol. 2002;161:1647–56.CrossRefPubMedPubMedCentral
8.
go back to reference Li M, Chen H, Diao L, Zhang Y, Xia C, Yang F. Caveolin-1 and vegf-c promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Tumori. 2010;96:734–43.PubMed Li M, Chen H, Diao L, Zhang Y, Xia C, Yang F. Caveolin-1 and vegf-c promote lymph node metastasis in the absence of intratumoral lymphangiogenesis in non-small cell lung cancer. Tumori. 2010;96:734–43.PubMed
9.
go back to reference Wang R, Li Z, Guo H, Shi W, Xin Y, Chang W, et al. Caveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer bt474 cells. Mol Med Rep. 2014;9:1723–8.PubMed Wang R, Li Z, Guo H, Shi W, Xin Y, Chang W, et al. Caveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer bt474 cells. Mol Med Rep. 2014;9:1723–8.PubMed
10.
go back to reference Yu X, Riley T, Levine AJ. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J. 2009;276:2201–12.CrossRefPubMed Yu X, Riley T, Levine AJ. The regulation of the endosomal compartment by p53 the tumor suppressor gene. FEBS J. 2009;276:2201–12.CrossRefPubMed
11.
go back to reference Marrazzo E, Marchini S, Tavecchio M, Alberio T, Previdi S, Erba E, et al. The expression of the deltanp73beta isoform of p73 leads to tetraploidy. Eur J Cancer. 2009;45:443–53.CrossRefPubMed Marrazzo E, Marchini S, Tavecchio M, Alberio T, Previdi S, Erba E, et al. The expression of the deltanp73beta isoform of p73 leads to tetraploidy. Eur J Cancer. 2009;45:443–53.CrossRefPubMed
12.
go back to reference Vikhanskaya F, Clerico L, Valenti M, Stanzione MS, Broggini M, Parodi S, et al. Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53. Int J Cancer. 1997;72:155–9.CrossRefPubMed Vikhanskaya F, Clerico L, Valenti M, Stanzione MS, Broggini M, Parodi S, et al. Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: Possible role of p53. Int J Cancer. 1997;72:155–9.CrossRefPubMed
13.
go back to reference Marabese M, Mazzoletti M, Vikhanskaya F, Broggini M. Htra2 enhances the apoptotic functions of p73 on bax. Cell Death Differ. 2008;15:849–58.CrossRefPubMed Marabese M, Mazzoletti M, Vikhanskaya F, Broggini M. Htra2 enhances the apoptotic functions of p73 on bax. Cell Death Differ. 2008;15:849–58.CrossRefPubMed
14.
go back to reference Marabese M, Vikhanskaya F, Broggini M. P73: a chiaroscuro gene in cancer. Eur J Cancer. 2007;43:1361–72.CrossRefPubMed Marabese M, Vikhanskaya F, Broggini M. P73: a chiaroscuro gene in cancer. Eur J Cancer. 2007;43:1361–72.CrossRefPubMed
15.
go back to reference Nunez-Wehinger S, Ortiz RJ, Diaz N, Diaz J, Lobos-Gonzalez L, Quest AF. Caveolin-1 in cell migration and metastasis. Curr Mol Med. 2014;14:255–74.CrossRefPubMed Nunez-Wehinger S, Ortiz RJ, Diaz N, Diaz J, Lobos-Gonzalez L, Quest AF. Caveolin-1 in cell migration and metastasis. Curr Mol Med. 2014;14:255–74.CrossRefPubMed
16.
go back to reference Zhang H, Su L, Muller S, Tighiouart M, Xu Z, Zhang X, et al. Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer. 2008;99:1684–94.CrossRefPubMedPubMedCentral Zhang H, Su L, Muller S, Tighiouart M, Xu Z, Zhang X, et al. Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma. Br J Cancer. 2008;99:1684–94.CrossRefPubMedPubMedCentral
17.
go back to reference Chiu WT, Lee HT, Huang FJ, Aldape KD, Yao J, Steeg PS, et al. Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res. 2011;71:4932–43.CrossRefPubMedPubMedCentral Chiu WT, Lee HT, Huang FJ, Aldape KD, Yao J, Steeg PS, et al. Caveolin-1 upregulation mediates suppression of primary breast tumor growth and brain metastases by stat3 inhibition. Cancer Res. 2011;71:4932–43.CrossRefPubMedPubMedCentral
18.
go back to reference Quann K, Gonzales DM, Mercier I, Wang C, Sotgia F, Pestell RG, et al. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide. Cell Cycle. 2013;12:1510–20.CrossRefPubMedPubMedCentral Quann K, Gonzales DM, Mercier I, Wang C, Sotgia F, Pestell RG, et al. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide. Cell Cycle. 2013;12:1510–20.CrossRefPubMedPubMedCentral
19.
go back to reference Brodie SA, Lombardo C, Li G, Kowalski J, Gandhi K, You S, et al. Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced nsclc. PLoS One. 2014;9:e107124.CrossRefPubMedPubMedCentral Brodie SA, Lombardo C, Li G, Kowalski J, Gandhi K, You S, et al. Aberrant promoter methylation of caveolin-1 is associated with favorable response to taxane-platinum combination chemotherapy in advanced nsclc. PLoS One. 2014;9:e107124.CrossRefPubMedPubMedCentral
20.
go back to reference Pancotti F, Roncuzzi L, Maggiolini M, Gasperi-Campani A. Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of stat3 signaling. Cell Signal. 2012;24:1390–7.CrossRefPubMed Pancotti F, Roncuzzi L, Maggiolini M, Gasperi-Campani A. Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of stat3 signaling. Cell Signal. 2012;24:1390–7.CrossRefPubMed
21.
go back to reference Salem AF, Bonuccelli G, Bevilacqua G, Arafat H, Pestell RG, Sotgia F, et al. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous e-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle. 2011;10:3692–700.CrossRefPubMedPubMedCentral Salem AF, Bonuccelli G, Bevilacqua G, Arafat H, Pestell RG, Sotgia F, et al. Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous e-cadherin via suppression of the epithelial-mesenchymal transition. Cell Cycle. 2011;10:3692–700.CrossRefPubMedPubMedCentral
22.
go back to reference Chunhacha P, Chanvorachote P. Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. Int J Physiol Pathophysiol Pharmacol. 2012;4:149–55.PubMedPubMedCentral Chunhacha P, Chanvorachote P. Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. Int J Physiol Pathophysiol Pharmacol. 2012;4:149–55.PubMedPubMedCentral
23.
go back to reference Chunhacha P, Pongrakhananon V, Rojanasakul Y, Chanvorachote P. Caveolin-1 regulates mcl-1 stability and anoikis in lung carcinoma cells. Am J Physiol Cell Physiol. 2012;302:C1284–92.CrossRefPubMedPubMedCentral Chunhacha P, Pongrakhananon V, Rojanasakul Y, Chanvorachote P. Caveolin-1 regulates mcl-1 stability and anoikis in lung carcinoma cells. Am J Physiol Cell Physiol. 2012;302:C1284–92.CrossRefPubMedPubMedCentral
24.
go back to reference Halim H, Luanpitpong S, Chanvorachote P. Acquisition of anoikis resistance up-regulates caveolin-1 expression in human non-small cell lung cancer cells. Anticancer Res. 2012;32:1649–58.PubMed Halim H, Luanpitpong S, Chanvorachote P. Acquisition of anoikis resistance up-regulates caveolin-1 expression in human non-small cell lung cancer cells. Anticancer Res. 2012;32:1649–58.PubMed
25.
go back to reference Wang Z, Wang N, Li W, Liu P, Chen Q, Situ H, et al. Caveolin-1 mediates chemoresistance in breast cancer stem cells via beta-catenin/abcg2 signaling pathway. Carcinogenesis. 2014;35:2346–56.CrossRefPubMed Wang Z, Wang N, Li W, Liu P, Chen Q, Situ H, et al. Caveolin-1 mediates chemoresistance in breast cancer stem cells via beta-catenin/abcg2 signaling pathway. Carcinogenesis. 2014;35:2346–56.CrossRefPubMed
Metadata
Title
∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299
Authors
Elisa Caiola
Eleonora Marrazzo
Simona Alesci
Massimo Broggini
Mirko Marabese
Publication date
01-02-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 2/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4012-z

Other articles of this Issue 2/2016

Tumor Biology 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine